Wider economic impact Fast food and weight loss companies aside, the life sciences, food and beverage industries must look at the wider economic impact of the GLP-1 megatrend
ADA: Once-Weekly Cagrilintide + Semaglutide Promising in Type 2 Diabetes FRIDAY, June 12, 2026 -- Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter 2 inhibitor (SGLT2i), and using basal insulin, according to three studies published online June 7 in The Lancet Diabetes & Endocrinology and The Lancet to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans
This use of Akkermansia supplementation has been shown to be effective at similar levels as a dietary intervention and can pave a path for the prevention of prediabetes
Order a water test or call ETR at (800) 344-9977 if you have any questions.
pmid:2295962 20
Mader, J.S., Ewen, C., Hancock, R.E., and Bleackley, R.C., J
